Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,963 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HER family in cancer progression: From discovery to 2020 and beyond.
Kumar R, George B, Campbell MR, Verma N, Paul AM, Melo-Alvim C, Ribeiro L, Pillai MR, da Costa LM, Moasser MM. Kumar R, et al. Among authors: ribeiro l. Adv Cancer Res. 2020;147:109-160. doi: 10.1016/bs.acr.2020.04.001. Epub 2020 Jun 5. Adv Cancer Res. 2020. PMID: 32593399 Review.
Pretreatment hemoglobin level as a prognostic factor in patients with locally advanced head and neck squamous cell carcinoma.
Melo-Alvim C, Miguel-Semedo P, Paiva RS, Lobo-Martins S, Luna-Pais H, Costa AL, Santos AR, Florindo A, Vasconcelos AL, Abrunhosa-Branquinho AN, Palmela P, Fernandes L, Presa DL, Costa L, Ribeiro L. Melo-Alvim C, et al. Among authors: ribeiro l. Rep Pract Oncol Radiother. 2020 Sep-Oct;25(5):768-774. doi: 10.1016/j.rpor.2020.07.002. Epub 2020 Jul 28. Rep Pract Oncol Radiother. 2020. PMID: 32802001 Free PMC article.
Breast Sarcomas, Phyllodes Tumors, and Desmoid Tumors: Turning the Magnifying Glass on Rare and Aggressive Entities.
Esperança-Martins M, Melo-Alvim C, Dâmaso S, Lopes-Brás R, Peniche T, Nogueira-Costa G, Abreu C, Luna Pais H, de Sousa RT, Torres S, Gallego-Paez LM, Martins M, Ribeiro L, Costa L. Esperança-Martins M, et al. Among authors: ribeiro l. Cancers (Basel). 2023 Aug 2;15(15):3933. doi: 10.3390/cancers15153933. Cancers (Basel). 2023. PMID: 37568749 Free PMC article. Review.
Promoting physical activity through supervised vs motivational behavior change interventions in breast cancer survivors on aromatase inhibitors (PAC-WOMAN): protocol for a 3-arm pragmatic randomized controlled trial.
Carraça EV, Rodrigues B, Franco S, Nobre I, Jerónimo F, Ilharco V, Gabriel F, Ribeiro L, Palmeira AL, Silva MN. Carraça EV, et al. Among authors: ribeiro l. BMC Cancer. 2023 Jul 5;23(1):632. doi: 10.1186/s12885-023-11137-1. BMC Cancer. 2023. PMID: 37407950 Free PMC article.
Prognostic factors for patients treated with abiraterone.
Alvim CM, Mansinho A, Paiva RS, Brás R, Semedo PM, Lobo-Martins S, da Ponte CB, Macedo D, Ribeiro L, Dos Reis JP, Fernandes I, Costa L. Alvim CM, et al. Among authors: ribeiro l. Future Sci OA. 2019 Dec 12;6(2):FSO436. doi: 10.2144/fsoa-2019-0079. Future Sci OA. 2019. PMID: 32025327 Free PMC article.
Organization and implementation of a cardio-oncology program.
Fiuza M, Ribeiro L, Magalhães A, Sousa AR, Nobre Menezes M, Jorge M, Costa L, Pinto FJ. Fiuza M, et al. Among authors: ribeiro l. Rev Port Cardiol. 2016 Sep;35(9):485-94. doi: 10.1016/j.repc.2016.04.006. Epub 2016 Aug 5. Rev Port Cardiol. 2016. PMID: 27503589 Free article. Review. English, Portuguese.
Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study.
O'Shaughnessy J, Sousa S, Cruz J, Fallowfield L, Auvinen P, Pulido C, Cvetanovic A, Wilks S, Ribeiro L, Burotto M, Klingbiel D, Messeri D, Alexandrou A, Trask P, Fredriksson J, Machackova Z, Stamatovic L; PHranceSCa study group. O'Shaughnessy J, et al. Among authors: ribeiro l. Eur J Cancer. 2021 Jul;152:223-232. doi: 10.1016/j.ejca.2021.03.047. Epub 2021 Jun 16. Eur J Cancer. 2021. PMID: 34147014 Free article. Clinical Trial.
1,963 results